FDA Panel Vote Against Availability of New Weight Loss Pill Qnexa
Links shared publicly online about this topic.
- 1,019total visits
FDA Panel Vote Against Availability of New Weight Loss Pill Qnexa
Availability of Vivus's new weight loss pill, Qnexa, in question as FDA advisory panel recommends against diet drug's approval following safety concerns.
View full resource at news.suite101.com
Tags: Obesity Medication, Diet and Nutrition, Weight Loss, Drug, FDA, Qnexa
Most Recently Shared on July 16, 2010 at 6:52 am By:
FDA Panel Vote Against Availability of New Weight Loss Pill Qnexa: Availability of Vivus's new weight loss pill, Q... http://bit.ly/cRzg9X
Advertisement
